Sort
17,828 grants matching “crispr”
Utilizing the Chicken Embryo to Decode the Transcriptional Regulation of FOXE3
$214,227Michael L Robinson · Miami University Oxford · R21 · FY2025 · EY
Human Genetics and Microbiome Core
$214,217Mark J Daly · Massachusetts General Hospital · P30 · FY2021 · DK
The molecular basis of 7SK RNA methylation in non-small cell lung cancer
$213,881Mingyi Xie · University Of Florida · R21 · FY2025 · CA
CRISPR and Virulence Core
$213,876Bridget Marie Barker · University Of California, San Francisco · U19 · FY2023 · AI
Core 4 Sali Echeverria
$213,689Andrej Sali · University Of California, San Francisco · U54 · FY2022 · AI
Epigenetic mechanisms of anhedonia and fear in AUD
$213,553Katherine Miles Johnston McMurray · University Of Illinois At Chicago · P50 · FY2025 · AA
TERT Promoter Mutations and Telomerase Reactivation in Cancer Cells
$213,405Thomas R Cech · University Of Colorado · R01 · FY2017 · GM
Reprogramming of human dermal fibroblasts into inductive dermal papilla cells
$213,345Yuhang Zhang · University Of Cincinnati · R21 · FY2021 · AR
CRISPR-Cas9 editing in C9orf72 patient derived iPSC
$213,300Claire Clelland · University Of California, San Francisco · K08 · FY2020 · NS
CRISPR-Cas9 editing in C9orf72 patient derived iPSC
$213,300Claire Clelland · University Of California, San Francisco · K08 · FY2021 · NS
CRISPR-Cas9 editing in C9orf72 patient derived iPSC
$213,300Claire Clelland · University Of California, San Francisco · K08 · FY2022 · NS
TERT Promoter Mutations and Telomerase Reactivation in Cancer Cells
$213,234Thomas R Cech · University Of Colorado · R01 · FY2018 · GM
Lentivirus Construct Core
$213,200Olin D. Liang · Rhode Island Hospital · P30 · FY2023 · GM
Mechanism Underlying Sleep Disruption by Mammary Tumors
$213,180Randy J Nelson · West Virginia University · R21 · FY2023 · CA
TERT Promoter Mutations and Telomerase Reactivation in Cancer Cells
$213,054Thomas R Cech · University Of Colorado · R01 · FY2019 · GM
Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy
$212,878Jeffrey J. Ishizuka · Yale University · K08 · FY2024 · CA
Organoid Acquired Resistance
$212,804Sourav Bandyopadhyay · University Of California, San Francisco · U54 · FY2025 · CA
CRISPR tools to dissect the coding and non-coding genome
$212,696Joana De Campos Alves Vidigal · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2019 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2020 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2018 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2021 · CA
Somatic Engineering-based Models of Pancreatic Cancer
$212,580Monte Meier Winslow · Stanford University · R21 · FY2015 · CA
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy
$212,579Shana O Kelley · University Of Toronto · R01 · FY2021 · CA
Improved Mouse Modeling of 25 to 300-Kilobase-Scale Human Genomic Structural Variation by CRISPR/Cas9-Stimulated Homologous Recombination of BacterialArtificial Chromosome Vectors (CRISPR/BAC/HR)
$212,500David E Bergstrom · Jackson Laboratory · R21 · FY2019 · OD